According to Athira Pharma's latest financial reports the company has $0.12 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.14 B | -26.42% |
2022-12-31 | $0.20 B | -21.05% |
2021-12-31 | $0.25 B | 37.4% |
2020-12-31 | $0.18 B | 8882.59% |
2019-12-31 | $2.05 M | -57.32% |
2018-12-31 | $4.81 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | $0.31 B | 159.47% | ๐บ๐ธ USA |